D-0277-2025 Class II Ongoing
FDA drug recall D-0277-2025 was initiated by Rising Pharma Holding, Inc. on Mar 5, 2025 and is designated Class II. Reason for recall: CGMP Deviations: Presence of N-nitroso-duloxetine impurity above recommended interim limit. The recall status is ongoing. Affected quantity: 1223 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Mar 26, 2025
- Initiation Date
- Mar 5, 2025
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 1223 bottles
Product description
Duloxetine Delayed-Release Capsules, USP, 30 mg, 1,000-count bottle, Rx only, Distributed by: Rising Health, LLC, Saddle Brook, NJ 07663, NDC 57237-018-99
Reason for recall
CGMP Deviations: Presence of N-nitroso-duloxetine impurity above recommended interim limit.
Distribution pattern
Nationwide in the USA.
Code information
Lot #: DTB23111A, Exp 8/31/2025
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0277-2025
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026